| Literature DB >> 24059691 |
Rajeswaran Jagadeesan1, Amelia Fotheringham, Paul R Ebert, David I Schlipalius.
Abstract
BACKGROUND: Next-generation sequencing technology is an important tool for the rapid, genome-wide identification of genetic variations. However, it is difficult to resolve the 'signal' of variations of interest and the 'noise' of stochastic sequencing and bioinformatic errors in the large datasets that are generated. We report a simple approach to identify regional linkage to a trait that requires only two pools of DNA to be sequenced from progeny of a defined genetic cross (i.e. bulk segregant analysis) at low coverage (<10×) and without parentage assignment of individual SNPs. The analysis relies on regional averaging of pooled SNP frequencies to rapidly scan polymorphisms across the genome for differential regional homozygosity, which is then displayed graphically.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24059691 PMCID: PMC3849015 DOI: 10.1186/1471-2164-14-650
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Figure 1Outline of the crossing scheme and sequencing strategy.
Results summary of sequencing and read mapping
| SICS/SRB | F4 Unselected | 36 (paired) | 49,636,554 | 28,119,799 | 1,012,312,764 | 5× | 556,683 |
| SICS/SRB | F4 Selected | 36 (paired) | 52,622,706 | 28,155,197 | 1,013,587,092 | 5× | 297,483 |
| SICS/SRA | F19 Unselected | 75 (unpaired) | 7,944,144 | 6,443,622 | 483,271,650 | 2.4× | 310,852 |
| SICS/SRA | F19 Selected | 75 (paired) | 15,643,072 | 12,246,096 | 918,457,200 | 4.5× | 602,068 |
Figure 2Average SNP frequency across Chr8 Chr9 and Uns-7, from A) Fand B) Fdatasets (Selected vs Unselected). The window size used was an average of 300 cells (or 50 cells for Uns-7) in the spreadsheet analysis. The x-axis is a non-linear scale determined by the number of SNPs in the dataset. The regions showing linkage to resistance are highlighted by a dashed arrow; solid arrow indicates regions where the resistance loci were confirmed by fine-scale linkage mapping.
Figure 3Fine-scale mapping of Chr8 defining the candidate region _ The numbers of recombinants for each marker across the region are highlighted in pink, with the defined region containing resistance locus tc_rph1 in red.
Figure 4Linkage mapping of unassigned scaffold (Uns) - 7 postioning it on chromosome 9. The region highlighted in red on Uns-7 contains the known DLD resistance locus (tc_rph2).
List of candidate genes for phosphine resistance in Chr8 and Chr9 (Uns-7)
| TC005925 | EFA09201 | CG5255 | 7.00E-28 | Trypsin like serine protease H65 |
| TC005926 | EFA08291 | NA | NA | Unknown function |
| TC005927 | EFA08292 | CG13804 | 3.00E-150 | Yellow-g2 |
| TC005928 | EFA08293 | CG6543 | 3.00E-158 | Cyclohex-1-ene-1-carboxyl-CoA hydratase; enoyl CoA hydratase |
| TC005929 | EFA08294 | CG2663 | 3.00E-36 | Sec14p-like lipid-binding domain; Alpha tocopherol transfer protein |
| TC005930 | EFA08295 | CG13096 | 1.00E-28 | Ribosomal protein L1 |
| TC005931 | EFA08296 | NA | NA | Unknown function |
| TC005932 | EFA08297 | CG5670 | 0 | Na(+)/K(+) ATPase alpha subunit |
| TC006224 | EFA08569 | CG12880 | 5.00E-29 | Unknown function |
| TC006225 | EFA08570 | CG7463 | 1.00E-06 | Yellow-k |
| TC006226 | EFA08571 | CG5717 | 3.00E-160 | Yellow-g |
| TC006227 | EFA08572 | CG9792 | 1.00E-116 | Yellow-e |
| TC006228 | EFA08573 | NA | | Unknown function |
| TC006229 | EFA08574 | CG9891 | 9.00E-89 | Yellow-e3 |
| TC006230 | EFA08575 | CG1629 | 2.00E-132 | Yellow-h |
| TC006231 | EFA08576 | CG13279 | 9.00E-104 | Cytochrome b5 related; Fatty acid desaturase |
| TC006232 | EFA08577 | CG13279 | 1.00E-117 | Cytochrome b5 related; Fatty acid desaturase |
| TC006821 | EFA13109 | CG17514 | 0 | Translational activator gcn-1, partial; Translator activator activity |
| TC006822 | EFA13110 | CG7430 | 1.00E-48 | Dihydrolipoamide dehydrogenase E3 subunit |
| TC006823 | EFA13111 | CG7430 | 1.00E-82 | Dihydrolipoamide dehydrogenase E3 subunit |
| TC006824 | EFA13130 | CG42698 | 7.00E-111 | Pou domain motif 3 |
| TC006825 | EFA13112 | CG6551 | 3.00E-104 | Serine/threonine protein kinase |
| TC006826 | EFA13113 | CG6551 | 8.00E-38 | Serine/threonine protein kinase |
| TC006827 | EFA13114 | CG6551 | 6.00E-38 | Serine/threonine protein kinase |
| TC006828 | EFA13115 | CG6178 | 5.00E-87 | Fatty acetyl coA synthese activity |
| TC006829 | NA | CG11715 | 4.37E-08 | Cytochrome P450; Cyp4g15 |
| TC006830 | EFA13116 | CG3800 | 1.00E-03 | Polyprotein; Nucleic acid binding protein |
| TC006831 | EFA13117 | CG14660 | 3.90E-02 | Putative serine protease; Labial associated factor |
| TC006832 | EFA13118 | CG3104 | 1.00E-18 | Dopamine transporter; Ankyrin repeats involving in protein-protein interactions |
| TC006833 | EFA13119 | CG6178 | 5.00E-102 | AMP binding enzyme; Fatty aceyl coA synthese activity |
| TC006834 | EFA13120 | CG6551 | 6.00E-17 | Serine/threonine protein kinase; ATP Binding |
| TC006835 | EFA13121 | CG3104 | 2.00E-18 | Dopamine transporter; Ankyrin repeats involving in protein-protein interactions |
| TC006836 | EFA13122 | NA | NA | Unknown function |
| TC006837 | EFA13123 | CG42231 | 3.00E-10 | Unknown function; Uncharacterized conserved protein |
| TC006838 | EFA13124 | CG5245 | 6.25E-49 | Nucleic acid/Zinc ion binding |
| TC006840 | EFA13125 | CG14938 | 3.00E-56 | Nucleic acid/Zinc ion binding |
Relative contribution of resistance loci, tc_and tc_
| tc_ | tc_ | US* | 0.008 | 0.01 | 0.02 | 0.03 | 0.05 | 0.06 | 0.1 | 0.2 | 0.5 | 0.8 | 1 | 2 | 3 | 4 |
| 6 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| 16 | 11 | 6 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| 15 | 8 | 6 | 15 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| 8 | 4 | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| 25 | 21 | 29 | 5 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| 18 | 16 | 19 | 31 | 19 | 5 | 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| 3 | 0 | 2 | 1 | 1 | 7 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| 2 | 3 | 3 | 2 | 10 | 9 | 6 | 8 | 1 | 3 | 0 | 0 | 0 | 0 | 0 | ||
| 0 | 1 | 4 | 7 | 4 | 11 | 3 | 5 | 7 | 7 | 4 | 3 | 3 | 3 | 1 | ||
| PCR amplified | 96 | 90 | 71 | 68 | 44 | 32 | 28 | 14 | 10 | 10 | 4 | 4 | 4 | 3 | 2 | |
| Survivors | 202 | 107 | 155 | 90 | 75 | 40 | 30 | 14 | 11 | 11 | 4 | 6 | 4 | 3 | 3 | |
| Total no.of insects bioassayed | 202 | 130 | 201 | 201 | 200 | 313 | 204 | 295 | 312 | 300 | 320 | 302 | 310 | 300 | 320 | |
*US = Unselected beetles.
Fitness analysis of resistance loci, tc_and tc_over 18 generations in the absence of phosphine selection
| F2 | 94 | 28 | 41 | 27 | 0.51 | 0.49 | 2.15 | 0.143 |
| F5 | 94 | 34 | 43 | 17 | 0.59 | 0.41 | 6.83* | 0.009 |
| F10 | 96 | 38 | 45 | 13 | 0.63 | 0.37 | 13.4** | <0.001 |
| F15 | 95 | 35 | 46 | 14 | 0.61 | 0.39 | 9.38* | 0.002 |
| F20 | 96 | 38 | 48 | 8 | 0.65 | 0.34 | 18.8** | <0.001 |
| F2 | 94 | 20 | 52 | 22 | 0.49 | 0.51 | 1.15 | 0.283 |
| F5 | 96 | 5 | 54 | 37 | 0.33 | 0.67 | 22.8** | <0.001 |
| F10 | 92 | 7 | 38 | 45 | 0.29 | 0.71 | 33.6** | <0.001 |
| F15 | 96 | 0 | 28 | 64 | 0.15 | 0.85 | 99.0** | <0.001 |
| F20 | 96 | 0 | 36 | 58 | 0.19 | 0.81 | 75.2** | <0.001 |
* Significant (P < 0.01); ** Significant (P < 0.001).
† Significance values are calculated from deviation from Hardy-Weinberg equilibrium compared to expected F2 (1:2:1) ratio.